Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer (opens in a new tab)
Status unknownPhase 2
Prostatic NeoplasmsProstatic DiseasesPomegranate liquid extract
Dr. Arie Belldegrun, MD
NPI1013932847
- Medicare services, 2016
- 12
- Part D claims, 2018
- 12
- Publications
- 134
- Clinical trials
- 11
- Industry payments
- $1.8M
- Practice address
- 200 Medical Plaza Ste 140 Suite 140, Los Angeles, CA 90095
- Practice phone
- Call (310) 794-7700
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Ucla Urology Associates
Surgical practice · Los Angeles, California
Find Dr. Belldegrun's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Arie Belldegrun is a urologist in Marrero, Louisiana
Dr. Belldegrun practices at Ucla Urology Associates in Los Angeles, California.
Dr. Belldegrun's NPI, 1013932847, was assigned on July 13, 2006. Dr. Belldegrun graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1975. Dr. Belldegrun's California license number on file is A44477.
NPI and contact details
- NPI
- 1013932847NPI Registry (opens in a new tab)
- NPI enumeration date
- July 13, 2006
- NPI status
- Active
- Practice phone
- (310) 794-7700
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1975
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Arie Belldegrun practices in Los Angeles and Marrero
Dr. Belldegrun's primary practice is Ucla Urology Associates, at 200 Medical Plaza Ste 140 Suite 140, Los Angeles, CA 90095. The practice phone is (310) 794-7700. The NPI Registry lists Dr. Belldegrun's practice address as 1101 Medical Center Blvd, Marrero, LA 70072.
- Ucla Urology AssociatesPrimary200 Medical Plaza Ste 140 Suite 140, Los Angeles, CA 90095Phone(310) 794-7700
- NPI Registry address1101 Medical Center Blvd, Marrero, LA 70072 · Jefferson ParishPhone(310) 794-7700
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Practice Data
Dr. Arie Belldegrun is affiliated with 2 sites of care and 1 medical group
Dr. Belldegrun's primary practice is Ucla Urology Associates in Los Angeles, California. The medical group on file is UCLA Urology. Dmand AI also links Dr. Belldegrun to 1 more physician office, named with a free account.
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dmand AI tracks the EHR system at Dr. Arie Belldegrun's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Belldegrun practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Ucla Urology Associates | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Belldegrun practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Arie Belldegrun is one of 179 urologists in Louisiana
Urology is Dr. Belldegrun's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Belldegrun's licenses on file in 4 states: California, New York, Massachusetts and Virginia.
Specialties and state licenses
- Urology, CaliforniaPrimary
- New York license
- Massachusetts license
- Virginia license
Urologists near Dr. Belldegrun
Counts of urologists with a Dmand AI profile, by place and practice. Each opens the list.
179urologists in Louisiana
5urologists in Marrero
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Arie Belldegrun billed Medicare for 12 services in 2016
CMS data shows 12 Medicare services from Dr. Belldegrun across 1 procedure code in 2016, all of them office visits. Medicare paid $656 for them. Every service was in an office.
Medicare services, 201612
Paid by Medicare$656
Procedure codes1
Dr. Belldegrun compared with the Louisiana median for urologists, 2016
- Dr. Belldegrun
- Louisiana median
- Medicare services
- 12vs 95699% below
- Part D claims
- 12vs 1,12199% below
Medians across 182 urologists in Louisiana with Dmand AI profiles that report each measure.
Dr. Belldegrun's most billed Medicare procedure codes, 2016
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Belldegrun?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Belldegrun and other urologists in Louisiana.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Arie Belldegrun wrote 12 Medicare Part D claims in 2018
In 2018, Dr. Belldegrun wrote 12 Medicare Part D claims. They cover 1 drug, with $3,213 in total drug cost.
Part D claims, 201812
Drugs named by CMS1
Total drug cost$3,213
Dr. Belldegrun's most prescribed drugs by claims, 2018
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find urologists like Dr. Belldegrun by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Arie Belldegrun has 134 publications on record
Dmand AI links 134 papers to Dr. Belldegrun, published from 2006 to 2018. 2011 was the busiest year, with 7. The most frequent topics are Kidney Neoplasms, Carcinoma, Renal Cell and Interleukin-2. Dr. Belldegrun has published most often in J Urol. Dr. Belldegrun's most frequent co-authors are Robert Alan Figlin, MD, Jean Dekernion, MD and Allan Pantuck, MD.
Papers134
Years published2006 to 2018
Dr. Belldegrun's papers by year, 2007 to 2018
Topics Dr. Belldegrun writes about most
- Kidney Neoplasms
- Carcinoma, Renal Cell
- Interleukin-2
- Prostatic Neoplasms
- Lymphocytes, Tumor-Infiltrating
- Tumor Cells, Cultured
- Nephrectomy
- Immunotherapy
Dr. Belldegrun's most frequent co-authors
- Robert Alan Figlin, MD36 shared papers
- Jean Dekernion, MD22 shared papers
- Allan Pantuck, MD22 shared papers
Recent publications by Dr. Belldegrun
See who Dr. Belldegrun researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Belldegrun works with, so you can find a warm path to the right urologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Arie Belldegrun has worked on 11 clinical trials
Dmand AI links Dr. Belldegrun to 11 clinical trials, 5 of them phase 2 studies. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Carcinoma, Renal Cell. Jonsson Comprehensive Cancer Center sponsors the most, 5.
Clinical trials with Dr. Belldegrun by phase
- 3Phase 1: 3 trials
- 1Phase 1/2: 1 trial
- 5Phase 2: 5 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Belldegrun's trials
- Prostatic Neoplasms
- Prostatic Diseases
- Carcinoma, Renal Cell
- Esophageal Neoplasms
- Urinary Bladder Neoplasms
Investigators on the most trials with Dr. Belldegrun
Recent clinical trials with Dr. Belldegrun
Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer (opens in a new tab)
Status unknownPhase 2
Prostatic NeoplasmsProstatic DiseasesPomegranate extractPomegranate juice
Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy (opens in a new tab)
CompletedPhase 1
Prostatic NeoplasmsProstatic DiseasesSU011248
Prostatic NeoplasmsProstatic DiseasesPomegranate juice
Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer (opens in a new tab)
CompletedPhase 3
Carcinoma, Renal CellKidney NeoplasmsGirentuximab
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Arie Belldegrun received $1,800,699 in industry payments from 2021 to 2025
CMS Open Payments shows 68 general payments to Dr. Belldegrun from 3 drug and device companies from 2021 to 2025. Speaker and faculty fees make up the largest share, 99% of the total. Urogen Pharma, Inc. paid the most, $1,800,446.
General payments to Dr. Belldegrun by program year, 2021 to 2025
General payments to Dr. Belldegrun by kind, 2021 to 2025
$1.8Min total
- Speaker and faculty fees$1,779,96899%
- Travel and lodging$18,6481%
- Food and beverage$2,0830%
Companies that paid Dr. Belldegrun the most, 2021 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Arie Belldegrun has 6 awards and honors on record
Dmand AI lists 6 awards for Dr. Belldegrun, most recently America's Top Doctors in 2014.
Awards and honors for Dr. Belldegrun
- 2014
- America's Top Doctors
- 2013
- America's Top Doctors for Cancer
- Top Doctors:LA Area
- 2012
- Top Doctors:Southern California
- Undated
- ACS Fellow
- Super Doc
Source: Dmand AI Professional Profile Data
Dr. Arie Belldegrun graduated from The Hebrew University of Jerusalem Hadassah Medical School
Dr. Belldegrun graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1975. Dr. Belldegrun is a member of ACS.
- Medical school
Source: Dmand AI Professional Profile Data
Dr. Arie Belldegrun accepts plans from 13 insurance carriers
Dr. Belldegrun is in network with 13 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Elevance
- HCSC
- Aetna
- Blue Cross Blue Shield of Massachusetts
- Regence Health Plans
- Alliant Health Plans
- +5 more carriersWith a free account
Plan types Dr. Belldegrun accepts, by number of carriers
- PPO9
- HMO7
- Medicare5
- EPO3
- POS2
Source: Dmand AI Insurance Network Data
Sources for Dr. Arie Belldegrun's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Arie Belldegrun
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Arie Belldegrun's NPI number?
Dr. Arie Belldegrun's NPI number is 1013932847. It was assigned on July 13, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Arie Belldegrun?
Dr. Arie Belldegrun is a urologist in Marrero, Louisiana. The primary specialty in the NPI Registry is Urology Physician (taxonomy code 208800000X).
Where does Dr. Arie Belldegrun practice?
Dr. Belldegrun practices at 200 Medical Plaza Ste 140 Suite 140, Los Angeles, CA 90095. Dr. Belldegrun also practices at 1101 Medical Center Blvd, Marrero, LA 70072. Dr. Belldegrun's primary practice is Ucla Urology Associates in Los Angeles, California. Dmand AI also links Dr. Belldegrun to 1 physician office.
What is Dr. Arie Belldegrun's office phone number?
The practice phone on file for Dr. Belldegrun is (310) 794-7700.
What is Dr. Arie Belldegrun's medical license number?
Dr. Belldegrun's California license number on file is A44477, one of the licenses on file in 4 states.
Which states has Dr. Arie Belldegrun been licensed in?
Dmand AI has state licenses on file for Dr. Belldegrun in California (1988 to 2025), New York (1987 to 2026), Massachusetts (1983 to 2003) and Virginia (1985 to 2000).
What medical group is Dr. Arie Belldegrun part of?
Dr. Belldegrun is linked to UCLA Urology.
Does Dr. Arie Belldegrun accept Medicare?
Yes. CMS data shows Dr. Belldegrun billed Medicare for 12 services in 2016.
What services does Dr. Arie Belldegrun bill to Medicare?
In 2016, Dr. Belldegrun's most billed Medicare services were office visit, established patient (99213).
Where did Dr. Arie Belldegrun go to medical school?
Dr. Belldegrun graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1975.
Show 6 more questionsShow fewer questions
What drugs does Dr. Arie Belldegrun prescribe most?
In 2018 Medicare Part D data, Dr. Belldegrun's most prescribed drugs by claims were Rapaflo.
Has Dr. Arie Belldegrun received payments from drug or device companies?
CMS Open Payments shows $1,800,699 in general payments to Dr. Belldegrun from 3 companies from 2021 to 2025. The largest total came from Urogen Pharma, Inc.
How long has Dr. Arie Belldegrun been practicing?
Dr. Belldegrun graduated from medical school in 1975, 51 years ago.
Does Dr. Arie Belldegrun do research?
Dmand AI links 134 publications to Dr. Belldegrun, published from 2006 to 2018. Dr. Belldegrun has worked on 11 clinical trials.
Who does Dr. Arie Belldegrun publish with?
Dr. Belldegrun's most frequent co-authors are Robert Alan Figlin, MD (36 shared papers), Jean Dekernion, MD (22 shared papers) and Allan Pantuck, MD (22 shared papers).
What insurance does Dr. Arie Belldegrun accept?
Dr. Belldegrun is in network with 13 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to urology practices?
See urologists in Louisiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card